Navigation Links
Express Scripts Holding Company Announces Fourth Quarter 2012 Earnings Conference Call
Date:1/17/2013

ST. LOUIS, Jan. 17, 2013 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX), the largest pharmacy benefit management company in North America, announced today its intention to release its fourth quarter earnings on Monday, February 18, 2013 at approximately 4:00 p.m. Eastern Time (3:00 p.m. Central Time) and will hold its quarterly conference call to discuss fourth quarter results on Tuesday, February 19, 2013, at 9:00 a.m. Eastern Time (8:00 a.m. Central Time).

This call is being webcast and can be accessed at Express Scripts' web site at www.express-scripts.com/corporate

Due to the Federal Holiday on Monday, February 18, 2013, the Company expects to file its Annual Report on Form 10-K for the year ended December 31, 2012 with the Securities and Exchange Commission on Tuesday, February 19, 2013.  However, in connection with the Company's earnings release, the content of the Form 10-K (without exhibits) substantially in the form to be filed on Tuesday, February 19, 2013, is expected to be made available to the public on the "Investor Information" section of the Company's website at approximately 4:00 pm Eastern Time (3:00 p.m. Central Time) on Monday, February 18, 2013 at www.express-scripts.com/corporate.

About Express Scripts
Express Scripts (NASDAQ: ESRX) manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients – employers, health plans, unions and government health programs – we make the use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities – behavioral sciences, clini
'/>"/>

SOURCE Express Scripts Holding Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Express Scripts to Present at Bank of America Merrill Lynch Conference
2. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
3. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
4. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
5. Generex Augments Antigen Express Scientific Advisory Board
6. Law Office of Brodsky & Smith, LLC Announces Investigation of SRI Surgical Express, Inc.
7. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
8. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
9. Express Scripts Holding Company Announces Second Quarter 2012 Earnings Conference Call
10. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
11. Express Scripts Reports Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015  The report on breast cancer therapeutics: ... cancer drugs on the basis of the molecules which ... the inner lining of milk ducts or lobules responsible ... of tumor that can spread to other cells present ... in lobules is referred as lobular carcinoma, while the ...
(Date:9/2/2015)... LONDON , Sept. 2, 2015 ... Forecasts Summary Advanced dressings have steadily ... treatment of a variety of wound indications, such ... fluid management, infection control, and physical protection become ... a greater role in standard therapy. This ...
(Date:9/2/2015)... MONROVIA, Calif. , Sept. 2, 2015 STAAR ... and marketer of implantable lenses and delivery systems for the ... William P. Wall to the Company,s Board. ... Abrams Capital, a Boston -based investment firm, ... member of the Board of Directors, and chair of the ...
Breaking Medicine Technology:Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Advanced Wound Dressings - 5EU Analysis and Market Forecasts 2William P. Wall Appointed to STAAR Surgical Board of Directors 2
... CEL-SCI Corporation,(Amex: CVM ) announced today that it ... its lead drug Multikine(R) on October 8, 2008.,This dedicated ... for,CEL-SCI,s pivotal Phase III clinical trial for first-line therapy ... for,sale following approval of the drug. The facility, which ...
... 0901 is Being Developed as an Oral Dosage Form ... at Improving Glycemic Control in Adults With Type 2 ... (OTCBB: ORMP.OB), a developer of oral drug delivery,systems, announced ... a GLP1-analog., ORMD 0901 belongs to the Incretin ...
Cached Medicine Technology:CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008 2CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008 3Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform 2
(Date:9/2/2015)... ... September 02, 2015 , ... The CRISPR-Cas9 system introduces double-strand DNA ... Cas9 nuclease with either a chimeric single guide RNA (sgRNA) or two short RNAs ... guide RNA (sgRNA or crRNA) to create a break in the target DNA that ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... healthcare innovation and investment, announced the two leaders who will deliver keynote presentations ... November 3, at the Mandarin Oriental Hotel in Boston. , Larry Renfro, CEO ...
(Date:9/2/2015)... ... 2015 , ... Telehealth represents a growing trend among Blue Cross and Blue ... of more than 12 Blues plan clients. The September 2015 issue of ... growing trend, interviewing executives at Capital Blue Cross, whose telehealth services will launch next ...
(Date:9/2/2015)... Athyn, PA (PRWEB) , ... September 02, 2015 , ... ... Heilman Hall at Bryn Athyn Church Elementary School, 600 Tomlinson Road, Bryn Athyn, Pa ... Inc., will host a day-long seminar featuring New York Times best-selling author Sam Keen ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... ambulatory healthcare industry announced today the launch of its enhanced, cloud-based mobile ePrescribing ... “new look” and focus on improving prescriber usability. A leader in health technology, ...
Breaking Medicine News(10 mins):Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 3Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 4Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 3Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 2Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 3Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:RxNT Releases Enhanced ePrescribing iPhone App to Improve Prescriber Usability 2
... Clinic to Automate Three Offices with High Performance DR ... ... /PRNewswire-FirstCall/ - IDC (Imaging Dynamics Company,Ltd.) (TSX: IDL), the global leader ... a contract by,Orthopaedic Clinic of Daytona Beach in Florida for four ...
... Blue Cross ... ... California,(Blue Cross) today announced the inclusion of HealthCare Partners Medical,Group and ... preferred provider, effective January 1, 2008., HealthCare Partners serves more ...
... Feb. 4, 2008 Theres new hope for breast ... place. Researchers at the Texas A&M University College of ... the journals Molecular and Cellular Biology and Carcinogenesis indicating ... in Down Syndrome may also contribute to treating this ...
... Forms Alliance With Veterinary News Network, MODESTO, ... in,veterinary hospital captive audience digital signage solutions and ... one of the,most comprehensive client education systems in ... partnering with emebaVet, bringing interesting,and accurate pet health ...
... Feb. 4 George Abercrombie, president and chief,executive ... Atlanta,business leaders today at a Rotary Club of ... presents businesses with challenges unlike those,anticipated with traditional ... too familiar with preparing for potential,disasters such as ...
... 4 In the first study to directly compare ... indicated overall satisfaction with the vaginal ring, researchers report ... publication of the American College of Obstetricians and Gynecologists. ... birth control pills, these products became available in 2002 ...
Cached Medicine News:Health News:Orthopaedic Clinic of Daytona Beach Chooses IDC for Transition to Digital X-ray 2Health News:HealthCare Partners Physicians Join Blue Cross of California 'Power Select HMO' Network 2Health News:Vet medicine researcher examines link between cancer, Down syndrome 2Health News:emebaVet, LLC Client Education System Gets Bigger and Better in 2008 2Health News:emebaVet, LLC Client Education System Gets Bigger and Better in 2008 3Health News:CEO Addresses Georgia Business Leaders About Developing Pandemic and Business Continuity Plans 2Health News:CEO Addresses Georgia Business Leaders About Developing Pandemic and Business Continuity Plans 3Health News:Ringing endorsement: Women prefer contraceptive ring over patch 2
... 525 is an assayed quality control ... of blood gas, electrolyte, metabolite, and ... this control makes it the ideal ... It is available in three (3) ...
Xsera Rapid HIV-1/2 Antibody Controls are unassayed positive and negative quality control materials used for monitoring the performance of qualitative rapid HIV-1 and HIV-2 test kits....
For the qualitative detection of igG antibodies specific to Helicobacter pylori in human serum, plasma and whole blood specimens...
For the qualitative detection of human occult blood in fecal specimens....
Medicine Products: